Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Latest Articles

  • You have access
    Newer oral and noninsulin therapies to treat type 2 diabetes mellitus
    Kathie L. Hermayer, MD, MS and Andrew Dake, MD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5 suppl 1) S18-S26; DOI: https://doi.org/10.3949/ccjm.83.s1.04
  • You have access
    Predicting is tough, especially about the future
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 324; DOI: https://doi.org/10.3949/ccjm.83b.05016

    All risk calculators—not just for anticoagulation—are based on the “average” patient. And no patient is average.

  • You have access
    How can I predict bleeding in my elderly patient taking anticoagulants?
    Gene R. Quinn, MD, MS and Margaret C. Fang, MD, MPH
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 345-348; DOI: https://doi.org/10.3949/ccjm.83a.15002

    We have tools, but their predictive value is modest. Clinical judgment is important.

  • You have access
    Self-monitoring of blood glucose: Advice for providers and patients
    Shannon Knapp, BSN, RN, CDE, Pooja Manroa, MD and Krupa Doshi, MD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 355-360; DOI: https://doi.org/10.3949/ccjm.83a.14147

    Self-monitoring provides essential data and also motivates patients. A certified diabetes educator can help.

  • You have access
    The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk
    Courtney Nagel Sandler, MD and Marie E. McDonnell, MD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5 suppl 1) S4-S10; DOI: https://doi.org/10.3949/ccjm.83.s1.02
  • You have access
    Phrenic nerve paralysis induced by brachial plexus block
    Aaron C. Hamilton, MD, MBA and Christopher Pleyer, MD
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 250-251; DOI: https://doi.org/10.3949/ccjm.83a.15032

    The patient developed shortness of breath 1 day after undergoing arthroscopic repair of a rotator cuff.

  • You have access
    Managing diabetes in hospitalized patients with chronic kidney disease
    Shridhar N. Iyer, MD, PhD, FACP and Robert J. Tanenberg, MD, FACP
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 301-310; DOI: https://doi.org/10.3949/ccjm.83a.14189

    Avoiding hypoglycemia takes precedence over meeting strict blood sugar targets.

  • You have access
    Drugs that may harm bone: Mitigating the risk
    Faye N. Hant, DO, MSCR and Marcy B. Bolster, MD
    Cleveland Clinic Journal of Medicine April 2016, 83 (4) 281-288; DOI: https://doi.org/10.3949/ccjm.83a.15066

    The implicated drugs have important therapeutic roles, so their benefits must be weighed against the risks.

  • You have access
    In reply: The PARADIGM-HF trial (October 2015)
    Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 167-168; DOI: https://doi.org/10.3949/ccjm.83c.03002
  • You have access
    Advances in the treatment of dyslipidemia
    Marc S. Sabatine, MD, MPH
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 181-186; DOI: https://doi.org/10.3949/ccjm.83gr.16001

    Current guidelines do not set specifi c targets for LDL-C, but evidence supports the concept that lower is better.

Pages

  • Previous
  • Next
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire